BioSpace News Archive

Genetown

NanoView Biosciences to Present at the Biotech Showcase™ Annual Conference on January 14, 2020

NanoView Biosciences, Inc., announced that Jerry Williamson, Chief Executive Officer, is scheduled to present at Biotech Showcase™ 2020 taking place on January 13-15, 2020 at the Hilton San Francisco Union Square, San Francisco, CA.

January 8, 2020
·
1 min read
Business

Xencor and Gilead Enter License Agreement for Use of XmAb® Antibody Technologies in Investigational Agents for HIV

Xencor, Inc. announced it has entered into a technology license agreement in which Gilead Sciences, Inc., will access Xencor’s Xtend™ extended half-life and Cytotoxic XmAb® Fc technologies for developing and commercializing GS-9722, Gilead’s first-in-class effector-enhanced broadly neutralizing anti-HIV antibody, which is currently in Phase 1 clinical development.

January 8, 2020
·
4 min read
Job Trends

Moleculera Labs’ Study Demonstrates Clinical Utility and Accuracy of the Cunningham Panel in Patients With Symptoms of Autoimmune Encephalopathy

Positive correlation seen between the Cunningham Panel assay results and patients’ neuropsychiatric symptoms

January 8, 2020
·
5 min read
Business

Zimmer Biomet Appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer

Keri P. Mattox has been appointed to the newly created position of Senior Vice President, Investor Relations and Chief Communications Officer.

January 8, 2020
·
2 min read
Biotech Beach

AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.

AXIM® Biotechnologies, Inc. announced that the Company has signed a binding term sheet to acquire leading oncology research and development company Sapphire Biotech, Inc. as a wholly-owned subsidiary.

January 8, 2020
·
5 min read
Biotech Beach

Therapeutic Solutions International Reports Inhibition of Microglial Activation with NeuroStilbene

Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal and human brain cell data demonstrating inhibition in microglial activation of IL-1 beta, IL-6, and TNF-a. NeuroStilbene was also shown to induce neurogenic growth factors and protected from peroxide and kainic-acid induced apoptosis.

January 8, 2020
·
4 min read
Biotech Beach

Biocept, Inc. Awarded United States Patent for the Use of Antibodies in Combination with Any Solid Surface to Detect Any Target Cell of Interest - from Any Sample Type

Biocept further expands its patent estate for capturing and detecting target cells of interest, including circulating tumor cells

January 8, 2020
·
4 min read
Business

Solidia Technologies and Uncountable Accelerate Development of Next-Generation Concrete Manufacturing with Data Science and AI

New enterprise software platform brings data revolution to cement and concrete

January 8, 2020
·
4 min read
FDA

U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of MYCAMINE® (micafungin for injection) for the Treatment of Invasive Candidiasis in Pediatric Patients Less Than 4 Months of Age

Astellas Pharma Inc. announced that the U.S. Food and Drug Administration has approved its supplemental New Drug Application for MYCAMINE® in support of the treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age.

January 8, 2020
·
6 min read
Biotech Beach

AnaptysBio to Present at J.P. Morgan Annual Healthcare Conference

J.P. Morgan 38th Annual Healthcare Conference on Wednesday, Jan. 15, 2020 at 2:30 p.m. PT at the Westin St. Francis in San Francisco.

January 8, 2020
·
1 min read